Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NICE To Lose Cost Watch-dog Status By 2013

Nov 01 2010

Related Content

NICE Enough? Watchdog's Basic Approach Is Sound, But More Transparency Is Urged

Jul 23 2009

UK's New Cancer Drug Fund Might Not Alleviate Regional Access Disparities

Nov 01 2010

Additional Topics

Regulation Reimbursement

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window